Serum levels of homocysteine, asymmetric dimethylarginine and nitric oxide in patients with Parkinson's disease

Kirbas S., Kirbas A., Tufekci A., Cure M. C., Cakmak S., Yazici T., ...Daha Fazla

ACTA CLINICA BELGICA, cilt.71, sa.2, ss.71-75, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 71 Sayı: 2
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1080/17843286.2016.1138592
  • Dergi Adı: ACTA CLINICA BELGICA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.71-75
  • Anahtar Kelimeler: Asymmetric dimethylarginine, Nitric oxide, Homocysteine, Parkinson's disease, ENDOTHELIAL DYSFUNCTION, HYPERHOMOCYSTEINAEMIA, METABOLISM, LINK
  • Recep Tayyip Erdoğan Üniversitesi Adresli: Evet

Özet

Objectives: Endothelial dysfunction has been implicated as a crucial event in the development of several neurodegenerative diseases. The aim of this study was to investigate the serum homocysteine, asymmetric dimethylarginine (ADMA) and nitric oxide (NO) levels in patients with Parkinson's disease (PD) and to compare the results with data from healthy controls.